Reimbursement Lag of New Drugs under Taiwan's National Health Insurance System compared to United Kingdom, Canada, Australia, Japan, and South Korea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reimbursement Lag of New Drugs under Taiwan's National Health Insurance System compared to United Kingdom, Canada, Australia, Japan, and South Korea

Published:2020-03-12 Issue: Volume: Page:
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Shih Yi‐Ru¹,Liao Kai‐Hsin¹²,Chen Yen‐Hui¹³²,Lin Fang‐Ju¹³²,Hsiao Fei‐Yuan¹³²

Affiliation:

1. Graduate Institute of Clinical Pharmacy College of Medicine National Taiwan University Taipei Taiwan

2. Department of Pharmacy National Taiwan University Hospital Taipei Taiwan

3. School of Pharmacy College of Medicine National Taiwan University Taipei Taiwan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12778

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Optional Delinked Reward System: Making Pharmaceutical Innovation Work for Everyone;Applied Health Economics and Health Policy;2023-12-22

2. Recommendations on Pharmacoeconomic guidelines for Turkey considering reference countries: A scoping review;Health Policy and Technology;2022-12

3. Drug Lag and Associated Factors for Approved Drugs in Korea Compared with the United States;International Journal of Environmental Research and Public Health;2022-03-01

4. Health insurance coverage and timely antenatal care attendance in sub-Saharan Africa;BMC Health Services Research;2022-02-11

5. Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis;Clinical and Translational Science;2020-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3